Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

The yin and yang of apolipoprotein CIII.

Åvall K, Berggren PO, Juntti-Berggren L.

Diabetes Metab. 2017 May 8. pii: S1262-3636(17)30064-2. doi: 10.1016/j.diabet.2017.03.009. [Epub ahead of print] No abstract available.

PMID:
28495365
2.

Apolipoprotein CIII is a new player in diabetes.

Juntti-Berggren L, Berggren PO.

Curr Opin Lipidol. 2017 Feb;28(1):27-31. doi: 10.1097/MOL.0000000000000372. Review.

PMID:
27875339
3.

Diabetes Prevention Through Antiviral Treatment in Biobreeding Rats.

Niklasson B, Arbrandt G, Kawecki A, Juntti-Berggren L, Berggren PO, Al-Qahtani SM, Gustafsson AL, Bryzgalova G, Klitz W.

Viral Immunol. 2016 Oct;29(8):452-458. Epub 2016 Aug 9.

PMID:
27505258
4.

Cathelicidins positively regulate pancreatic β-cell functions.

Sun J, Xu M, Ortsäter H, Lundeberg E, Juntti-Berggren L, Chen YQ, Haeggström JZ, Gudmundsson GH, Diana J, Agerberth B.

FASEB J. 2016 Feb;30(2):884-94. doi: 10.1096/fj.15-275826. Epub 2015 Nov 2.

PMID:
26527065
5.

The pancreatic β-cell in deadly encounter with apolipoprotein CIII.

Juntti-Berggren L, Ali Y, Berggren PO.

Cell Cycle. 2015;14(17):2715-6. doi: 10.1080/15384101.2015.1064677. Epub 2015 Jun 23. No abstract available.

6.

Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes.

Åvall K, Ali Y, Leibiger IB, Leibiger B, Moede T, Paschen M, Dicker A, Daré E, Köhler M, Ilegems E, Abdulreda MH, Graham M, Crooke RM, Tay VS, Refai E, Nilsson SK, Jacob S, Selander L, Berggren PO, Juntti-Berggren L.

Proc Natl Acad Sci U S A. 2015 May 19;112(20):E2611-9. doi: 10.1073/pnas.1423849112. Epub 2015 May 4.

7.

CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum.

Yang G, Shi Y, Yu J, Li Y, Yu L, Welling A, Hofmann F, Striessnig J, Juntti-Berggren L, Berggren PO, Yang SN.

Cell Mol Life Sci. 2015 Mar;72(6):1197-207. doi: 10.1007/s00018-014-1737-6. Epub 2014 Oct 8.

PMID:
25292336
8.

Defects in β-cell Ca2+ dynamics in age-induced diabetes.

Li L, Trifunovic A, Köhler M, Wang Y, Petrovic Berglund J, Illies C, Juntti-Berggren L, Larsson NG, Berggren PO.

Diabetes. 2014 Dec;63(12):4100-14. doi: 10.2337/db13-1855. Epub 2014 Jul 1.

9.

Apolipoprotein CIII hyperactivates β cell CaV1 channels through SR-BI/β1 integrin-dependent coactivation of PKA and Src.

Shi Y, Yang G, Yu J, Yu L, Westenbroek R, Catterall WA, Juntti-Berggren L, Berggren PO, Yang SN.

Cell Mol Life Sci. 2014 Apr;71(7):1289-303. doi: 10.1007/s00018-013-1442-x. Epub 2013 Aug 15.

10.

Localization of lipoprotein lipase and GPIHBP1 in mouse pancreas: effects of diet and leptin deficiency.

Nyrén R, Chang CL, Lindström P, Barmina A, Vorrsjö E, Ali Y, Juntti-Berggren L, Bensadoun A, Young SG, Olivecrona T, Olivecrona G.

BMC Physiol. 2012 Nov 27;12:14. doi: 10.1186/1472-6793-12-14.

11.

One-step purification of functional human and rat pancreatic alpha cells.

Köhler M, Daré E, Ali MY, Rajasekaran SS, Moede T, Leibiger B, Leibiger IB, Tibell A, Juntti-Berggren L, Berggren PO.

Integr Biol (Camb). 2012 Feb;4(2):209-19. doi: 10.1039/c2ib00125j. Epub 2012 Jan 20.

PMID:
22267247
12.

Transthyretin binds to glucose-regulated proteins and is subjected to endocytosis by the pancreatic β-cell.

Dekki N, Refai E, Holmberg R, Köhler M, Jörnvall H, Berggren PO, Juntti-Berggren L.

Cell Mol Life Sci. 2012 May;69(10):1733-43. doi: 10.1007/s00018-011-0899-8. Epub 2011 Dec 20.

PMID:
22183612
13.

Apolipoprotein CIII reduces proinflammatory cytokine-induced apoptosis in rat pancreatic islets via the Akt prosurvival pathway.

Størling J, Juntti-Berggren L, Olivecrona G, Prause MC, Berggren PO, Mandrup-Poulsen T.

Endocrinology. 2011 Aug;152(8):3040-8. doi: 10.1210/en.2010-1422. Epub 2011 Jun 21.

PMID:
21693679
14.

Lowering apolipoprotein CIII delays onset of type 1 diabetes.

Holmberg R, Refai E, Höög A, Crooke RM, Graham M, Olivecrona G, Berggren PO, Juntti-Berggren L.

Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10685-9. doi: 10.1073/pnas.1019553108. Epub 2011 Jun 13.

15.

Electrical short-circuit in β-cells from a patient with non-insulinoma pancreatogenous hypoglycemic syndrome (NIPHS): a case report.

Bränström R, Berglund E, Curman P, Forsberg L, Höög A, Grimelius L, Berggren PO, Mattsson P, Hellman P, Juntti-Berggren L.

J Med Case Rep. 2010 Sep 23;4:315. doi: 10.1186/1752-1947-4-315.

16.

Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action.

Wunderlich FT, Ströhle P, Könner AC, Gruber S, Tovar S, Brönneke HS, Juntti-Berggren L, Li LS, van Rooijen N, Libert C, Berggren PO, Brüning JC.

Cell Metab. 2010 Sep 8;12(3):237-49. doi: 10.1016/j.cmet.2010.06.011.

17.

Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats.

Holmberg R, Klitz W, Blixt M, Berggren PO, Juntti-Berggren L, Niklasson B.

Microbiol Immunol. 2009 Oct;53(10):567-72. doi: 10.1111/j.1348-0421.2009.00160.x.

18.

Breathless after separation... from tumour.

Catrina SB, Juntti-Berggren L.

Eur Respir J. 2008 Nov;32(5):1420-1. doi: 10.1183/09031936.00096008. No abstract available.

19.

Predictors of cognitive impairment in type 1 diabetes.

Brismar T, Maurex L, Cooray G, Juntti-Berggren L, Lindström P, Ekberg K, Adner N, Andersson S.

Psychoneuroendocrinology. 2007 Sep-Nov;32(8-10):1041-51. Epub 2007 Sep 19.

PMID:
17884300
20.

Glucose recruits K(ATP) channels via non-insulin-containing dense-core granules.

Yang SN, Wenna ND, Yu J, Yang G, Qiu H, Yu L, Juntti-Berggren L, Köhler M, Berggren PO.

Cell Metab. 2007 Sep;6(3):217-28.

21.

Type 1 diabetic serum interferes with pancreatic beta-cell Ca2+-handling.

Dekki N, Nilsson R, Norgren S, Rössner SM, Appelskog I, Marcus C, Simell O, Pugliese A, Alejandro R, Ricordi C, Berggren PO, Juntti-Berggren L.

Biosci Rep. 2007 Dec;27(6):321-6.

PMID:
17597394
22.

The BioBreeding rat diabetes model is infected with Ljungan virus.

Niklasson B, Hultman T, Kallies R, Niedrig M, Nilsson R, Berggren PO, Juntti-Berggren L, Efendic S, Lernmark A, Klitz W.

Diabetologia. 2007 Jul;50(7):1559-60. Epub 2007 Apr 4. No abstract available. Erratum in: Diabetologia. 2007 Oct;50(10):2227.

PMID:
17406852
23.

C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.

Ekberg K, Brismar T, Johansson BL, Lindström P, Juntti-Berggren L, Norrby A, Berne C, Arnqvist HJ, Bolinder J, Wahren J.

Diabetes Care. 2007 Jan;30(1):71-6.

PMID:
17192336
24.

Downregulation of EGF receptor signaling in pancreatic islets causes diabetes due to impaired postnatal beta-cell growth.

Miettinen PJ, Ustinov J, Ormio P, Gao R, Palgi J, Hakonen E, Juntti-Berggren L, Berggren PO, Otonkoski T.

Diabetes. 2006 Dec;55(12):3299-308.

25.

Transthyretin constitutes a functional component in pancreatic beta-cell stimulus-secretion coupling.

Refai E, Dekki N, Yang SN, Imreh G, Cabrera O, Yu L, Yang G, Norgren S, Rössner SM, Inverardi L, Ricordi C, Olivecrona G, Andersson M, Jörnvall H, Berggren PO, Juntti-Berggren L.

Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17020-5. Epub 2005 Nov 14.

26.

Removal of Ca2+ channel beta3 subunit enhances Ca2+ oscillation frequency and insulin exocytosis.

Berggren PO, Yang SN, Murakami M, Efanov AM, Uhles S, Köhler M, Moede T, Fernström A, Appelskog IB, Aspinwall CA, Zaitsev SV, Larsson O, de Vargas LM, Fecher-Trost C, Weissgerber P, Ludwig A, Leibiger B, Juntti-Berggren L, Barker CJ, Gromada J, Freichel M, Leibiger IB, Flockerzi V.

Cell. 2004 Oct 15;119(2):273-84.

27.

Apolipoprotein CIII promotes Ca2+-dependent beta cell death in type 1 diabetes.

Juntti-Berggren L, Refai E, Appelskog I, Andersson M, Imreh G, Dekki N, Uhles S, Yu L, Griffiths WJ, Zaitsev S, Leibiger I, Yang SN, Olivecrona G, Jörnvall H, Berggren PO.

Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10090-4. Epub 2004 Jun 21.

28.

Dihydroxyacetone-induced oscillations in cytoplasmic free Ca2+ and the ATP/ADP ratio in pancreatic beta-cells at substimulatory glucose.

Juntti-Berggren L, Webb DL, Arkhammar PO, Schultz V, Schweda EK, Tornheim K, Berggren PO.

J Biol Chem. 2003 Oct 17;278(42):40710-6. Epub 2003 Aug 12.

29.

Proinsulin C-peptide and its analogues induce intracellular Ca2+ increases in human renal tubular cells.

Shafqat J, Juntti-Berggren L, Zhong Z, Ekberg K, Köhler M, Berggren PO, Johansson J, Wahren J, Jörnvall H.

Cell Mol Life Sci. 2002 Jul;59(7):1185-9.

PMID:
12222964
30.

Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose.

Shiota C, Larsson O, Shelton KD, Shiota M, Efanov AM, Hoy M, Lindner J, Kooptiwut S, Juntti-Berggren L, Gromada J, Berggren PO, Magnuson MA.

J Biol Chem. 2002 Oct 4;277(40):37176-83. Epub 2002 Jul 30.

31.

Cyclin-dependent kinase 5 promotes insulin exocytosis.

Lilja L, Yang SN, Webb DL, Juntti-Berggren L, Berggren PO, Bark C.

J Biol Chem. 2001 Sep 7;276(36):34199-205. Epub 2001 Jul 6.

32.

Effects of serum from patients with type 1 diabetes on primary cerebellar granule cells.

Chandra J, Yang SN, Köhler M, Zaitsev S, Juntti-Berggren L, Berggren PO, Zhivotovsky B, Orrenius S.

Diabetes. 2001 Feb;50 Suppl 1:S77-81.

33.

Role of apoptosis in pancreatic beta-cell death in diabetes.

Chandra J, Zhivotovsky B, Zaitsev S, Juntti-Berggren L, Berggren PO, Orrenius S.

Diabetes. 2001 Feb;50 Suppl 1:S44-7.

34.

7beta-hydroxycholesterol induces Ca(2+) oscillations, MAP kinase activation and apoptosis in human aortic smooth muscle cells.

Ares MP, Pörn-Ares MI, Moses S, Thyberg J, Juntti-Berggren L, Berggren P, Hultgårdh-Nilsson A, Kallin B, Nilsson J.

Atherosclerosis. 2000 Nov;153(1):23-35.

PMID:
11058697
35.

Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes.

Juntti-Berggren L, Pigon J, Hellström P, Holst JJ, Efendic S.

Diabetes Nutr Metab. 2000 Feb;13(1):7-12.

PMID:
10824717
36.

An endogenous peptide isolated from the gut, NK-lysin, stimulates insulin secretion without changes in cytosolic free Ca2+ concentration.

Zaitsev SV, Andersson M, Efanov AM, Efanova IB, Ostenson CG, Juntti-Berggren L, Berggren PO, Mutt V, Efendić S.

FEBS Lett. 1998 Nov 20;439(3):267-70.

37.

X-ray microanalysis of in situ and isolated pancreatic islets.

Wróblewski R, Pålsgård E, Juntti-Berggren L, Berggren PO, Roomans GM.

Pancreas. 1998 Mar;16(2):134-40.

PMID:
9510135
38.

Ca2+ channel blockers verapamil and nifedipine inhibit apoptosis induced by 25-hydroxycholesterol in human aortic smooth muscle cells.

Ares MP, Pörn-Ares MI, Thyberg J, Juntti-Berggren L, Berggren PO, Diczfalusy U, Kallin B, Björkhem I, Orrenius S, Nilsson J.

J Lipid Res. 1997 Oct;38(10):2049-61.

39.

The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients.

Juntti-Berggren L, Pigon J, Karpe F, Hamsten A, Gutniak M, Vignati L, Efendic S.

Diabetes Care. 1996 Nov;19(11):1200-6.

PMID:
8908380
40.

Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.

Gutniak MK, Juntti-Berggren L, Hellström PM, Guenifi A, Holst JJ, Efendic S.

Diabetes Care. 1996 Aug;19(8):857-63.

PMID:
8842604
41.

Reversible Ca2+-dependent translocation of protein kinase C and glucose-induced insulin release.

Deeney JT, Cunningham BA, Chheda S, Bokvist K, Juntti-Berggren L, Lam K, Korchak HM, Corkey BE, Berggren PO.

J Biol Chem. 1996 Jul 26;271(30):18154-60.

42.

Interleukin-1 beta-induced stimulation of insulin release in mouse pancreatic islets is related to diacylglycerol production and protein kinase C activation.

Eizirik DL, Sandler S, Welsh N, Juntti-Berggren L, Berggren PO.

Mol Cell Endocrinol. 1995 Jun;111(2):159-65.

PMID:
7556877
43.

Effects of K(+)-induced depolarization and purinergic receptor activation on elemental content in insulin-producing RINm5F-cells.

Pålsgård E, Lindh U, Juntti-Berggren L, Berggren PO, Roomans GM.

Cell Biol Int. 1995 Jan;19(1):25-34.

PMID:
7613508
44.

Identification of synaptic proteins and their isoform mRNAs in compartments of pancreatic endocrine cells.

Jacobsson G, Bean AJ, Scheller RH, Juntti-Berggren L, Deeney JT, Berggren PO, Meister B.

Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12487-91.

45.

Glucose-stimulated increase in cytoplasmic pH precedes increase in free Ca2+ in pancreatic beta-cells. A possible role for pyruvate.

Juntti-Berggren L, Civelek VN, Berggren PO, Schultz V, Corkey BE, Tornheim K.

J Biol Chem. 1994 May 20;269(20):14391-5.

46.

Protein kinase C modulates the insulin secretory process by maintaining a proper function of the beta-cell voltage-activated Ca2+ channels.

Arkhammar P, Juntti-Berggren L, Larsson O, Welsh M, Nånberg E, Sjöholm A, Köhler M, Berggren PO.

J Biol Chem. 1994 Jan 28;269(4):2743-9.

47.

Proton-induced and electron-induced X-ray microanalysis of insulin-secreting cells.

Pålsgård E, Lindh U, Juntti-Berggren L, Berggren PO, Roomans GM, Grime GW.

Scanning Microsc Suppl. 1994;8:325-32; discussion 332-3.

PMID:
7638496
48.

Increased activity of L-type Ca2+ channels exposed to serum from patients with type I diabetes.

Juntti-Berggren L, Larsson O, Rorsman P, Ammälä C, Bokvist K, Wåhlander K, Nicotera P, Dypbukt J, Orrenius S, Hallberg A, et al.

Science. 1993 Jul 2;261(5117):86-90.

PMID:
7686306
49.

Regulation of cytoplasmic free Ca2+ in insulin-secreting cells.

Berggren PO, Arkhammar P, Islam MS, Juntti-Berggren L, Khan A, Kindmark H, Köhler M, Larsson K, Larsson O, Nilsson T, et al.

Adv Exp Med Biol. 1993;334:25-45. Review. No abstract available.

PMID:
8249687
50.

Induction of intercellular adhesion molecule-1 (CD54) on isolated mouse pancreatic beta cells by inflammatory cytokines.

Prieto J, Kaaya EE, Juntti-Berggren L, Berggren PO, Sandler S, Biberfeld P, Patarroyo M.

Clin Immunol Immunopathol. 1992 Dec;65(3):247-53.

PMID:
1360342

Supplemental Content

Loading ...
Support Center